Replimune, which suffered significant losses on July 22, 2025, after the FDA rejected its skin cancer treatment, is one of the top gainers in premarket trading today.
The following is the list of biotech stocks making big moves in premarket trading today.
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.